Somatic treatments for severe bipolar disorder

Charles H. Kellner; Joseph F. Goldberg; Mimi C. Briggs; Lauren S. Liebman; Gabriella M. Ahle

doi:10.1016/S0140-6736(13)61712-2

Somatic treatments for severe bipolar disorder

Charles H. Kellner
, Joseph F. Goldberg
, Mimi C. Briggs
, Lauren S. Liebman
, Gabriella M. Ahle

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	505-506
Number of pages	2
Journal	The Lancet
Volume	382
Issue number	9891
DOIs	https://doi.org/10.1016/S0140-6736(13)61712-2
State	Published - 2013

Access to Document

10.1016/S0140-6736(13)61712-2

Cite this

@article{4a65e36ced6e4e838c885bf7fa5f8cd5,

title = "Somatic treatments for severe bipolar disorder",

author = "Kellner, \{Charles H.\} and Goldberg, \{Joseph F.\} and Briggs, \{Mimi C.\} and Liebman, \{Lauren S.\} and Ahle, \{Gabriella M.\}",

note = "Funding Information: CHK has received grant support from the National Institute of Mental Health, honoraria from UpToDate and Psychiatric Times, and royalties from Cambridge University Press. JFG has been a consultant for Mylan and WebMD, received honoraria from MedScape and WebMD, served on the speakers/advisory boards of AstraZeneca, Merck, Novartis, Sunovion, and Mylan, and received royalties from American Psychiatric Publishing. The other authors declare that they have no conflicts of interest.",

year = "2013",

doi = "10.1016/S0140-6736(13)61712-2",

language = "English",

volume = "382",

pages = "505--506",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "9891",

}

TY - JOUR

T1 - Somatic treatments for severe bipolar disorder

AU - Kellner, Charles H.

AU - Goldberg, Joseph F.

AU - Briggs, Mimi C.

AU - Liebman, Lauren S.

AU - Ahle, Gabriella M.

N1 - Funding Information: CHK has received grant support from the National Institute of Mental Health, honoraria from UpToDate and Psychiatric Times, and royalties from Cambridge University Press. JFG has been a consultant for Mylan and WebMD, received honoraria from MedScape and WebMD, served on the speakers/advisory boards of AstraZeneca, Merck, Novartis, Sunovion, and Mylan, and received royalties from American Psychiatric Publishing. The other authors declare that they have no conflicts of interest.

PY - 2013

Y1 - 2013

UR - https://www.scopus.com/pages/publications/84881470012

U2 - 10.1016/S0140-6736(13)61712-2

DO - 10.1016/S0140-6736(13)61712-2

M3 - Letter

C2 - 23931923

AN - SCOPUS:84881470012

SN - 0140-6736

VL - 382

SP - 505

EP - 506

JO - The Lancet

JF - The Lancet

IS - 9891

ER -